SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects

Type 2 diabetes mellitus is a chronic metabolic disease associated with high cardiovascular (CV) risk. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are the latest class of antidiabetic medication that inhibit the absorption of glucose from the proximal tubule of the kidney and hence cause gly...

Descripción completa

Detalles Bibliográficos
Autores principales: Tentolouris, Anastasios, Vlachakis, Panayotis, Tzeravini, Evangelia, Eleftheriadou, Ioanna, Tentolouris, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720282/
https://www.ncbi.nlm.nih.gov/pubmed/31426529
http://dx.doi.org/10.3390/ijerph16162965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720282/
https://www.ncbi.nlm.nih.gov/pubmed/31426529
http://dx.doi.org/10.3390/ijerph16162965

Ejemplares similares